Advances in Cancer Immunotherapy™ - New Haven, CT

When:  Sep 16, 2017 from 08:00 to 14:00 (ET)


Omni New Haven Hotel at YaleNew Haven, CT

Mario Sznol, MD – Yale Cancer Center
Marianne Davies, DNP, AOCNP – Yale School of Nursing
Charles Lynch – Yale New Haven Hospital

ACI Program Registration Cost Information

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these six-hour programs will facilitate understanding of:

  • The rationale for common approaches to immunotherapy
  • The clinical applications of immunotherapy for disease states with FDA-approved treatments (melanoma, and lung, genitourinary, hematologic and head and neck cancers)
  • Operational and reimbursement barriers to implementing immunotherapy in a community setting and strategies to overcome them
  • The identification and management of immune-related adverse events from the nursing and prescriber perspective in the clinic and emergency settings

Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through two Immuno-Oncology Post-Program webinars after the program, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice. Breakfast and lunch will be served at the live portion of this event.

For more information, including program objectives, click here.

This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).      




Program Registration

This program has already taken place, to find information on upcoming programs, please check here.

SITC members are eligible for discounted registration rates. To receive discounted member rates, your membership dues must be current through 2017.

Click here to learn more about the registration rates for members and non-members for these programs.

Program Agenda

Preprogram Course: Introduction to Immunology

Participation in this online preprogram course is strongly recommended as it contains information that will not be covered at the program on September 16. This interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Please click HERE to access the course.

September 16 Program

5.5 AMA PRA Category 1 Credits™ Click here for more detailed CME, CNE and CPE information and program objectives.

Presentations include time for Audience Response System (ARS)-assisted audience
interaction as well as general question and answer time.

7 – 8 a.m.

Check-in, Onsite Registration and Networking

Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice

Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy

8 – 8:05 a.m.

Welcome, Introduction, and Pretest Questions by the Society for Immunotherapy of Cancer

8:05 – 8:35 a.m.

Basic Principles of Cancer Immunotherapy
Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center

8:35 – 8:55 a.m.

Immunotherapy for the Treatment of Melanoma
Sarah A. Weiss, MD – Yale Cancer Center

8:55 – 9:15 a.m.

Immunotherapy for the Treatment of Lung Cancer
Scott N. Gettinger, MD – Yale Cancer Center

9:15 – 9:35 a.m.

Immunotherapy for the Treatment of Genitourinary Cancers
Michael E. Hurwitz, MD, PhD – Yale Cancer Center

9:35 – 9:55 a.m

Immunotherapy for the Treatment of Hematologic Malignancies
Madhav Dhodapkar, MD – Yale Cancer Center

9:55 – 10:15 a.m

Immunotherapy for the Treatment of Head and Neck Cancers
Barbara A. Burtness, MD –Yale Cancer Center

10:15 – 10:25 a.m


Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice

10:25 – 10:30 a.m.

Information About the Society for Immunotherapy of Cancer Resources

10:30 – 11 a.m.

Effective Practices for Incorporating Immunotherapy Into Hospital Operations
Katherine Lin, PharmD, BCPS, BCOP – Yale-New Haven Hospital

11 – 11:30 a.m.

Coverage and Reimbursement Challenges and Strategies
Charles Lynch – Yale-New Haven Hospital

11:30 – 11:35 a.m.

Take-Home Points for Part A

11:35 a.m. – noon


Part B: Immune-Related Adverse Event (irAE) Management

noon – 12:20 p.m.

Mechanisms of Immune-Related Adverse Events
Harriet Kluger, MD – Yale Cancer Center

12:20 – 12:50 p.m.

Management and Mitigation of irAEs for Immunotherapy Prescribers
Marianne Davies, DNP, AOCNP – Yale School of Nursing
Harriet Kluger, MD – Yale Cancer Center

12:50 – 1:20 p.m.

Nursing Perspective on irAEs: Patient Education, Monitoring and Management
Marianne Davies, DNP, AOCNP – Yale School of Nursing

1:20 – 1:50 p.m.

Identification and Management of Immune-Related Adverse Events in the Emergency Setting
Ani Aydin, MD, FAAEM – Yale Cancer Center

1:50 – 1:55 p.m.

Posttest Questions by the Society for Immunotherapy of Cancer

1:55 – 2 p.m.

Take-Home Points for Part B and Closing Remarks

The 2017 Advances in Cancer Immunotherapy™ series is supported in part by independent medical educational grants
from Aduro Biotech, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Merck & Co., Inc. and Prometheus Laboratories Inc.

#CNE #HeadandNeckCancers #Cancer Immunotherapy Guidelines #CombinationTherapy #Patient #LungCancers #CPE #PrimaryCarePhysician #AdvancesinCancerImmunotherapy(ACI) #ProstateCancer #PatientAdvocate #Toxicities #HotTopic #SITC #AlliedHealth #InPersonEvent #Pharmacist #Clinician #Cytokines #Non-Profit #HematologicMalignancies #GenitourinaryCancers #CME #2017 #Adverse Events #Oncologist


Omni New Haven Hotel at Yale
155 Temple St.
New Haven, CT 06510